Cohen AT - Search Results

1

Prevention of venous thromboembolism in medical patients with enoxaparin: a subgroup analysis of the MEDENOX study.

Alikhan R, Cohen AT, Combe S, Samama MM, Desjardins L, Eldor A, Janbon C, Leizorovicz A, Olsson CG, Turpie AG. Alikhan R, et al. Among authors: cohen at. Blood Coagul Fibrinolysis. 2003 Jun;14(4):341-6. doi: 10.1097/00001721-200306000-00004. Blood Coagul Fibrinolysis. 2003. PMID: 12945875 Clinical Trial.

2

Duration of prophylaxis against venous thromboembolism with enoxaparin after surgery for cancer.

Bergqvist D, Agnelli G, Cohen AT, Eldor A, Nilsson PE, Le Moigne-Amrani A, Dietrich-Neto F; ENOXACAN II Investigators. Bergqvist D, et al. Among authors: cohen at. N Engl J Med. 2002 Mar 28;346(13):975-80. doi: 10.1056/NEJMoa012385. N Engl J Med. 2002. PMID: 11919306 Free article. Clinical Trial.

3

Discoveries in thrombosis care for medical patients.

Cohen AT. Cohen AT. Semin Thromb Hemost. 2002 Aug;28 Suppl 3:13-7. doi: 10.1055/s-2002-34081. Semin Thromb Hemost. 2002. PMID: 12232818 Review.

4

Risk factors for venous thromboembolism in orthopedic surgery.

Zaw HM, Osborne IC, Pettit PN, Cohen AT. Zaw HM, et al. Among authors: cohen at. Isr Med Assoc J. 2002 Nov;4(11):1040-2. Isr Med Assoc J. 2002. PMID: 12489502 Free article. Review. No abstract available.

5

Direct thrombin inhibitor melagatran followed by oral ximelagatran in comparison with enoxaparin for prevention of venous thromboembolism after total hip or knee replacement.

Eriksson BI, Agnelli G, Cohen AT, Dahl OE, Mouret P, Rosencher N, Eskilson C, Nylander I, Frison L, Ogren M; METHRO III Study Group. Eriksson BI, et al. Among authors: cohen at. Thromb Haemost. 2003 Feb;89(2):288-96. Thromb Haemost. 2003. PMID: 12574809 Clinical Trial.

6

A safety analysis of thromboprophylaxis in acute medical illness.

Alikhan R, Cohen AT. Alikhan R, et al. Among authors: cohen at. Thromb Haemost. 2003 Mar;89(3):590-1. Thromb Haemost. 2003. PMID: 12624645 No abstract available.

7

Correlation of plasma coagulation parameters with thromboprophylaxis, patient characteristics, and outcome in the MEDENOX study.

Desjardins L, Bara L, Boutitie F, Samama MM, Cohen AT, Combe S, Janbon C, Leizorovicz A, Olsson CG, Turpie AG. Desjardins L, et al. Among authors: cohen at. Arch Pathol Lab Med. 2004 May;128(5):519-26. doi: 10.5858/2004-128-519-COPCPW. Arch Pathol Lab Med. 2004. PMID: 15086284 Free article. Clinical Trial.

8

Risk factors for venous thromboembolism in hospitalized patients with acute medical illness: analysis of the MEDENOX Study.

Alikhan R, Cohen AT, Combe S, Samama MM, Desjardins L, Eldor A, Janbon C, Leizorovicz A, Olsson CG, Turpie AG; MEDENOX Study. Alikhan R, et al. Among authors: cohen at. Arch Intern Med. 2004 May 10;164(9):963-8. doi: 10.1001/archinte.164.9.963. Arch Intern Med. 2004. PMID: 15136304

9

Randomized, placebo-controlled trial of dalteparin for the prevention of venous thromboembolism in acutely ill medical patients.

Leizorovicz A, Cohen AT, Turpie AG, Olsson CG, Vaitkus PT, Goldhaber SZ; PREVENT Medical Thromboprophylaxis Study Group. Leizorovicz A, et al. Among authors: cohen at. Circulation. 2004 Aug 17;110(7):874-9. doi: 10.1161/01.CIR.0000138928.83266.24. Epub 2004 Aug 2. Circulation. 2004. PMID: 15289368 Clinical Trial.

10

Mortality rates and risk factors for asymptomatic deep vein thrombosis in medical patients.

Vaitkus PT, Leizorovicz A, Cohen AT, Turpie AG, Olsson CG, Goldhaber SZ; PREVENT Medical Thromboprophylaxis Study Group. Vaitkus PT, et al. Among authors: cohen at. Thromb Haemost. 2005 Jan;93(1):76-9. doi: 10.1160/TH04-05-0323. Thromb Haemost. 2005. PMID: 15630494

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

321 results

Search Page

Filters